Novanta Inc.
NMS: NOVTLive Quote
📈 ZcoreAI Score
Our AI model analyzes Novanta Inc.'s price action across multiple timeframes using regression channels and statistical scoring.
Get NOVT Z-Score →About Novanta Inc.
Technology
Scientific & Technical Instruments
Novanta Inc., together with its subsidiaries, provides precision medicine, precision manufacturing, medical solutions, robotics and automation solutions, and advanced surgery solutions in the United States and internationally. The company operates Automation Enabling Technologies and Medical Solutions segments. The Precision Medicine and Manufacturing segment designs, manufactures, and markets laser beam steering and scanning solutions, laser sources, robotic and precision motion, robotic end-of-arm tooling, and bearing spindles. This segment serves advanced industrial processes, advanced industrial and medical robotics, other medical and life science automation applications, and medical laser procedures, such as ophthalmology applications. The Medical Solutions segment provides a range of medical grade technologies, including medical insufflators, pumps, and related disposables; imaging, identification and RFID solutions; advanced motion control solutions; and light engines, and integrated operating room technologies. The company was formerly known as GSI Group, Inc. and changed its name to Novanta Inc. in May 2016. Novanta Inc. was incorporated in 1968 and is based in Bedford, Massachusetts.
📊 Fundamental Analysis
Novanta Inc. demonstrates a profit margin of 5.5%, which is below the sector average, suggesting competitive pressure.
The company recently reported 8.5% revenue growth, which is modest compared to its industry peers.
Return on Equity (ROE) is 5.2%, which suggests room for improvement in capital utilization.
At a current price of $125.23, NOVT currently sits at the 52nd percentile of its 52-week range (Range: $98.27 - $149.95).
💰 Valuation Insight
NOVT trades at a 184.0% premium to the sector average PE of 30.00. Analysts expect earnings growth, as indicated by a lower forward PE.
🏥 Financial Health
🔴
Profit Margin
Weak
✅
Debt/Equity
Excellent
🔴
Revenue Growth
Weak
🔴
Return on Equity
Weak
🔴
Beta (Risk)
High Volatility
Key Financials
Market Cap
$4.47B
Trailing P/E
85.19
Forward P/E
30.95
Beta (5Y)
1.65
52W High
$149.95
52W Low
$98.27
Avg Volume
412K
Day High
Day Low